Z-335 sodium

Details

Stereochemistry	RACEMIC
Molecular Formula	C18H17ClNO4S.Na
Molecular Weight	401.84
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Na+].[O-]C(=O)CC1=CC2=C(CC(CNS(=O)(=O)C3=CC=C(Cl)C=C3)C2)C=C1

InChI

InChIKey=UEPBEZPJELQKJV-UHFFFAOYSA-M

InChI=1S/C18H18ClNO4S.Na/c19-16-3-5-17(6-4-16)25(23,24)20-11-13-8-14-2-1-12(10-18(21)22)7-15(14)9-13;/h1-7,13,20H,8-11H2,(H,21,22);/q;+1/p-1

HIDE SMILES / InChI

Approval Year

PubMed

Title	Date	PubMed
Mechanism of hepatobiliary transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335), and its xenobiotic taurine conjugate (Z-335-Tau) in rats.	2003-01	12486683

Patents

Name

Type

Language

Z-335

Preferred Name

English

Z-335 sodium

Code

English

1H-Indene-5-acetic acid, 2-[[[(4-chlorophenyl)sulfonyl]amino]methyl]-2,3-dihydro-, sodium salt (1:1)

Systematic Name

English

1H-Indene-5-acetic acid, 2-[[[(4-chlorophenyl)sulfonyl]amino]methyl]-2,3-dihydro-, monosodium salt

Systematic Name

English

Sodium 2-(2-(((4-chlorophenyl)sulfonamido)methyl)-2,3-dihydro-1h-inden-5-yl)acetate

Systematic Name

English

Code System Code Type Description

PUBCHEM

23669776

Created by admin on Mon Mar 31 22:25:11 GMT 2025 , Edited by admin on Mon Mar 31 22:25:11 GMT 2025

PRIMARY

FDA UNII

STR7DVQ85U

Created by admin on Mon Mar 31 22:25:11 GMT 2025 , Edited by admin on Mon Mar 31 22:25:11 GMT 2025

PRIMARY

CAS

146731-14-8

Created by admin on Mon Mar 31 22:25:11 GMT 2025 , Edited by admin on Mon Mar 31 22:25:11 GMT 2025

PRIMARY

EPA CompTox

DTXSID20932899

Created by admin on Mon Mar 31 22:25:11 GMT 2025 , Edited by admin on Mon Mar 31 22:25:11 GMT 2025

PRIMARY

ACTIVE MOIETY


					STR7DVQ85U

Z-335 sodium